Therapeutic evaluation of phytochemicals present in Nigella sativa seed oil for anxiolytic activity against the GABA-B receptor: a gas chromatography-mass spectrometry (GC-MS)-supported molecular dynamics-based in silico study

利用气相色谱-质谱联用(GC-MS)技术结合分子动力学模拟方法,对黑种草籽油中植物化学成分的抗焦虑活性进行治疗评价,研究其作用于GABA-B受体。

阅读:1

Abstract

The current study aimed to explore the anxiolytic effects of phytochemicals present in Nigella sativa (black cumin) plant seeds. For that purpose, first we identified a plethora of bioactive phytocompounds by performing gas chromatography and mass spectrometry (GC-MS) analysis. GC-MS results revealed a total of 38 phytochemicals, including Guanosine 29.80%, Ethanamine 13.25%, Valeric acid, 2-tridecyl ester 12.48%, Pentanal 7.34%, 1-Dodecanol 5.65%, as the most abundant compounds, which represent 68% of the total chromatographic composition. The identified phytochemicals (ligands) from GCMS were subjected to molecular docking against the GABA-B (target protein) to screen top phytochemicals based on their docking scores. The docking results exhibited a range from - 2.5 (Ethanamine) to - 7.9 kcal/mol (Androstan-3-one). Furthermore, based on docking scores, the top six selected compounds, namely kasuminl, thunbergol, dehydro-cohumulinic acid, jasmoline, androstan-3-one, and hydrothymoquinone, were further checked for different pharmacological parameters such as ADME/T, biological activity, Lipinski's analysis, and physicochemical properties such as solubility (logS), lipophilicity (logP) and Total Polar Surface Area (tPSA). Moreover, molecular dynamics (MD) simulation trajectories such as RMSD, RMSF, Rg and SASA showed excellent dynamic behaviour, including structural stability, conformational flexibility and spatial organization over time. Overall, hydrothymoquinone, dehydro-cohumulinic acid, and androstan-3-one show great stability and favourable binding affinity against GABA-B. The collective results obtained from this study suggest that these natural phytochemicals derived from N. sativa may serve as lead compounds for anxiolytic effects. However, in-vitro and in-vivo studies are recommended to further validate their efficacy and establish them as drug candidates.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。